Apofasl as a novel treatment for type 1 diabetes in nonhuman primates
Ended Project Grant Awarded Last action
- Award ID
- R41DK081296
- Recipient
-
Apovax, Inc. UEI LT59MH2NTJP1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $850,924
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Place of performance
- Louisville, KY 40204, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $47,088 | |
| Amendment | $399,912 | |
| Original award | $403,924 |
Quick answers
Who received award R41DK081296?
R41DK081296 was awarded to Apovax, Inc. by National Institutes of Health (Department of Health and Human Services) on September 5, 2010.
How much is award R41DK081296 worth?
$850,924 has been obligated on R41DK081296.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award